Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a ...

Novo Nordisk is ending its partnership with Hims & Hers due to concerns over its practices related to compounded GLP-1s. By Marissa Plescia on June 24, 2025 7:21 pm Share ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

Hims is currently sat on a market cap of 12.6B, which is an 83% increase over the last 6 months, and a 133% increase YTD. However, I still believe the stock is very undervalued if you look at ...

Shares of Hims & Hers have surged 121.7% year to date compared with the industry’s gain of 22.9%. Image Source: Zacks Investment Research HIMS’ forward 12-month P/S of 4.7X is lower than the ...

Hims & Hers is also planning to introduce a new, personalized dimension of digital health in Europe. Through this, the company aims to provide individuals with access to care tailored to their ...

Hims & Hers (HIMS) is expanding its playbook across the Atlantic — the U.S.-based telehealth company announced Tuesday that it will acquire European telehealth platform Zava. The acquisition ...

Hims & Hers is a telemedicine platform that offers patients access to a variety of medications, including for skin care, anxiety, sexual health, ... Image source: Getty Images.

Expert Opinions on Hims & Hers Health. In the last month, 3 experts released ratings on this stock with an average target price of $43.33. Unusual Options Activity Detected: Smart Money on the Move ...